Article
Therapeutic Fc‐fusion proteins: Current analytical strategies
22 Sept 2020
Abstract excerpt
Fc-Fusion proteins represent a successful class of biopharmaceutical products, with already 13 drugs approved in the European Union and United States as well as three biosimilar versions of etanercept. Fc-Fusion products combine tailored pharmacological properties of biological ligands, together with multiple functions of the fragment crystallizable domain of immunoglobulins. There is a great diversity in terms...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
